135 related articles for article (PubMed ID: 37670618)
1. [Clinicopathological analysis of benign mammary ductal cystic papillomatosis with loss of myoepithelial cells].
An R; Ma ZY; Zhu HY; Zhang LY; Li L; Wang C; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2023 Sep; 52(9):902-906. PubMed ID: 37670618
[No Abstract] [Full Text] [Related]
2. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
Tramm T; Kim JY; Tavassoli FA
Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
[TBL] [Abstract][Full Text] [Related]
3. Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: a potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia.
Moritani S; Ichihara S; Kushima R; Okabe H; Bamba M; Kobayashi TK; Hattori T
Virchows Arch; 2007 May; 450(5):539-47. PubMed ID: 17377808
[TBL] [Abstract][Full Text] [Related]
4. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
Kővári B; Báthori Á; Cserni G
Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
[TBL] [Abstract][Full Text] [Related]
5. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells.
Popnikolov NK; Cavone SM; Schultz PM; Garcia FU
Mod Pathol; 2005 Dec; 18(12):1535-41. PubMed ID: 16258511
[TBL] [Abstract][Full Text] [Related]
7. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.
Moritani S; Kushima R; Sugihara H; Bamba M; Kobayashi TK; Hattori T
Mod Pathol; 2002 Apr; 15(4):397-405. PubMed ID: 11950913
[TBL] [Abstract][Full Text] [Related]
8. A case of intracystic apocrine papillary tumor: diagnostic pitfalls for malignancy.
Hayashi H; Ohtani H; Yamaguchi J; Shimokawa I
Pathol Res Pract; 2013 Dec; 209(12):808-11. PubMed ID: 24095109
[TBL] [Abstract][Full Text] [Related]
9. Intraductal proliferations of the breast: a review of histologic criteria for atypical intraductal hyperplasia and ductal carcinoma in situ, including apocrine and papillary lesions.
Purcell CA; Norris HJ
Ann Diagn Pathol; 1998 Apr; 2(2):135-45. PubMed ID: 9845731
[TBL] [Abstract][Full Text] [Related]
10. Mixed Invasive Apocrine Papillary/Micropapillary Carcinoma of the Breast: Another Brick in the Triple-Negative Wall.
Cima L; Mirabassi N; Sartori C; Carbone FG; Morelli L; Cserni G; Barbareschi M
Int J Surg Pathol; 2021 Jun; 29(4):420-426. PubMed ID: 32909476
[TBL] [Abstract][Full Text] [Related]
11. Artefactual Epithelial Displacement in a Papilloma with Extensive Usual Duct Hyperplasia Mimics a Solid Papillary Carcinoma with Invasive Growth.
François A; Galant C; Berlière M; Van Bockstal MR
Int J Surg Pathol; 2021 Jun; 29(4):395-399. PubMed ID: 33736513
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of benign and malignant papillary lesions of the breast.
Papotti M; Eusebi V; Gugliotta P; Bussolati G
Am J Surg Pathol; 1983 Jul; 7(5):451-61. PubMed ID: 6351647
[TBL] [Abstract][Full Text] [Related]
13. Benign apocrine papillary lesions of the breast lacking or virtually lacking myoepithelial cells-potential pitfalls in diagnosing malignancy.
Cserni G
APMIS; 2012 Mar; 120(3):249-52. PubMed ID: 22339683
[TBL] [Abstract][Full Text] [Related]
14. New trends of immunohistochemistry for making differential diagnosis of breast lesions.
Moriya T; Kasajima A; Ishida K; Kariya Y; Akahira J; Endoh M; Watanabe M; Sasano H
Med Mol Morphol; 2006 Mar; 39(1):8-13. PubMed ID: 16575508
[TBL] [Abstract][Full Text] [Related]
15. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].
Zhang B; Liu FF; Ma YJ; Gu F
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
Werling RW; Hwang H; Yaziji H; Gown AM
Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
[TBL] [Abstract][Full Text] [Related]
17. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast.
Ichihara S; Fujimoto T; Hashimoto K; Moritani S; Hasegawa M; Yokoi T
Pathol Int; 2007 Mar; 57(3):126-32. PubMed ID: 17295644
[TBL] [Abstract][Full Text] [Related]
18. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.
Celis JE; Moreira JM; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans V; Rank F
Mol Oncol; 2007 Jun; 1(1):97-119. PubMed ID: 19383289
[TBL] [Abstract][Full Text] [Related]
19. [Papillary lesions of the breast].
Länger F; Hille-Betz U; Kreipe HH
Pathologe; 2014 Feb; 35(1):36-44. PubMed ID: 24430780
[TBL] [Abstract][Full Text] [Related]
20. Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain.
Kalof AN; Tam D; Beatty B; Cooper K
J Clin Pathol; 2004 Jun; 57(6):625-9. PubMed ID: 15166269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
